Douglas Heuman Selected Research

Douglas Heuman Research Topics

4	Fibrosis (Cirrhosis) 01/2020 - 01/2010
2	Non-alcoholic Fatty Liver Disease 05/2020 - 06/2012
2	Hepatic Encephalopathy 11/2019 - 12/2017
2	Liver Diseases (Liver Disease) 01/2019 - 09/2010
2	Dysbiosis 12/2017 - 01/2017
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2019
1	End Stage Liver Disease 11/2019
1	Ascites 10/2012
1	Chronic Hepatitis C 07/2012
1	Infections 07/2012
1	Viremia 07/2012
1	Diabetic Nephropathies (Diabetic Nephropathy) 09/2010
1	Peritonitis 01/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2009
1	Philadelphia Chromosome 01/2009
1	Liver Neoplasms (Liver Cancer) 06/2007

1	Insulin (Novolin)FDA Link 05/2020
1	CarbohydratesIBA 05/2020
1	N- ((2,3- dihydro- 1,4- benzodioxin- 2- yl)methyl)- 5- methoxy- 1H- indole- 3- ethanamineIBA 11/2019
1	Antidepressive Agents (Antidepressants)IBA 11/2019
1	Psychotropic Drugs (Psychoactive Drugs)IBA 11/2019
1	Octreotide (Sandostatin)FDA LinkGeneric 10/2012
1	Vasoconstrictor AgentsIBA 10/2012
1	CreatinineIBA 10/2012
1	Midodrine (Midon)FDA LinkGeneric 10/2012
1	AlbuminsIBA 10/2012
1	SCY-635IBA 07/2012
1	Antiviral Agents (Antivirals)IBA 07/2012
1	InterferonsIBA 07/2012
1	Cyclophilins (Cyclophilin)IBA 07/2012
1	ElementsIBA 06/2012
1	LipidsIBA 06/2012
1	SulfotransferasesIBA 06/2012
1	SterolsIBA 06/2012
1	OxysterolsIBA 06/2012
1	Liver X ReceptorsIBA 06/2012
1	3,6- bis(N- fumaryl- N(n- butyl)amino)- 2,5- diketopiperazineIBA 09/2010
1	AcidsIBA 01/2010
1	Proton Pump InhibitorsIBA 01/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2010
1	nilotinib FDA Link 01/2009
1	bcr-abl Fusion ProteinsIBA 01/2009
1	Imatinib Mesylate (Gleevec)FDA Link 01/2009

4	Liver Transplantation 01/2020 - 06/2007
2	Therapeutics 11/2019 - 06/2007
1	Fecal Microbiota Transplantation 12/2017